Digoxin for reduction of circulating tumor cell cluster size in metastatic breast cancer: a proof-of-concept trial
Christian Kurzeder(University of Basel), Nicola Aceto(ETH Zurich)
Cited by 49
Related Papers
Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
|Cell|2014|2.5k
Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility
|Science|2014|911
A microfluidic device for label-free, physical capture of circulating tumor cell clusters
|Nature Methods|2015|726